| Glen Erik Tonnessen, MD | |
|
1100 Wescott Drive, Suite G 3, Flemington, NJ 08822 | |
| (908) 788-1710 | |
| (908) 788-1716 |
| Full Name | Glen Erik Tonnessen |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 1100 Wescott Drive, Flemington, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154387389 | NPI | - | NPPES |
| 5H53003 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MA055129 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hunterdon Medical Center | Flemington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hunterdon Cardiovascular Associates | 3779488242 | 19 |
| Hunterdon Medical Center | 9830009711 | 73 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
Although more than nine out of ten doctors believe it is appropriate to discuss religious or spiritual issues when a patient brings them up and three out of four encourage patients' religious beliefs and practices, only half inquire, even occasionally, about a patient's faith
Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.
Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).
› Verified 1 days ago
| Entity Name | Hunterdon Cardiovascular Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053334276 PECOS PAC ID: 3779488242 Enrollment ID: O20031208000004 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
Although more than nine out of ten doctors believe it is appropriate to discuss religious or spiritual issues when a patient brings them up and three out of four encourage patients' religious beliefs and practices, only half inquire, even occasionally, about a patient's faith
Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.
Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).
› Verified 1 days ago
| Entity Name | Hunterdon Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922095116 PECOS PAC ID: 9830009711 Enrollment ID: O20040927000892 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
Although more than nine out of ten doctors believe it is appropriate to discuss religious or spiritual issues when a patient brings them up and three out of four encourage patients' religious beliefs and practices, only half inquire, even occasionally, about a patient's faith
Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.
Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).
› Verified 1 days ago
| Entity Name | Hunterdon Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841560158 PECOS PAC ID: 9830009711 Enrollment ID: O20120328000177 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
Although more than nine out of ten doctors believe it is appropriate to discuss religious or spiritual issues when a patient brings them up and three out of four encourage patients' religious beliefs and practices, only half inquire, even occasionally, about a patient's faith
Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.
Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glen Erik Tonnessen, MD 1100 Wescott Drive, Suite G 3, Flemington, NJ 08822 Ph: (908) 788-1710 | Glen Erik Tonnessen, MD 1100 Wescott Drive, Suite G 3, Flemington, NJ 08822 Ph: (908) 788-1710 |
News Archive
"Hospital executives who have worked with Dr. Berwick describe him as a visionary, inspiring leader. But a battle has erupted over his nomination, suggesting that Dr. Berwick faces a long uphill struggle to win Senate confirmation. Republicans are using the nomination to revive their arguments against the new health care law, which they see as a potent issue in this fall's elections, and Dr. Berwick has given them plenty of ammunition. In two decades as a professor of health policy and as a prolific writer, he has spoken of the need to ration health care and cap spending and has confessed to a love affair with the British health care system."
Although more than nine out of ten doctors believe it is appropriate to discuss religious or spiritual issues when a patient brings them up and three out of four encourage patients' religious beliefs and practices, only half inquire, even occasionally, about a patient's faith
Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.
Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).
› Verified 1 days ago
Dr. Jeffrey D Hartford, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr, Suite 201, Flemington, NJ 08822 Phone: 908-788-6504 Fax: 908-788-6458 | |
Devi Patel, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr Ste 206, Flemington, NJ 08822 Phone: 908-788-6448 Fax: 908-483-4004 | |
Daniel Kobe, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1100 Wescott Dr Ste G3, Flemington, NJ 08822 Phone: 908-788-1710 | |
Kiera Farry, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr Ste G3, Flemington, NJ 08822 Phone: 908-788-1710 | |
Dr. Mary Jean Fusco, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4 Ups N Downs Ct, Flemington, NJ 08822 Phone: 908-782-0493 | |
Donald Stuart Novy, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6 Sand Hill Rd Ste 201, Flemington, NJ 08822 Phone: 908-237-4072 Fax: 908-782-7195 |